Rafferty Asset Management
CDNA icon

Rafferty Asset Management’s CareDx CDNA Stock Holding History

Rafferty Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$906K Sell
31,781
-46,953
-60% -$1.02M ﹤0.01% 803
2026
Q1 		$1.37M Sell
78,734
-12,400
-14% -$235K 0.01% 693
2025
Q4 		$1.72M Sell
91,134
-1,364
-1% -$22.9K 0.01% 685
2025
Q3 		$1.34M Buy
92,498
+21,129
+30% +$301K ﹤0.01% 731
2025
Q2 		$1.39M Sell
71,369
-27,960
-28% -$497K ﹤0.01% 696
2025
Q1 		$1.76M Sell
99,329
-20,469
-17% -$441K 0.01% 608
2024
Q4 		$2.56M Buy
119,798
+51,559
+76% +$1.25M 0.01% 575
2024
Q3 		$2.13M Sell
68,239
-21,195
-24% -$527K 0.01% 618
2024
Q2 		$1.39M Sell
89,434
-275,365
-75% -$3.33M 0.01% 742
2024
Q1 		$3.86M Buy
364,799
+174,401
+92% +$1.74M 0.01% 522
2023
Q4 		$2.28M Sell
190,398
-114,886
-38% -$941K 0.01% 638
2023
Q3 		$2.14M Sell
305,284
-37,671
-11% -$348K 0.01% 594
2023
Q2 		$2.92M Sell
342,955
-64,392
-16% -$537K 0.02% 536
2023
Q1 		$3.72M Sell
407,347
-78,036
-16% -$998K 0.03% 456
2022
Q4 		$5.54M Buy
485,383
+193,438
+66% +$2.87M 0.05% 356
2022
Q3 		$4.97M Buy
291,945
+123,736
+74% +$2.66M 0.05% 338
2022
Q2 		$3.61M Sell
168,209
-5,523
-3% -$153K 0.03% 350
2022
Q1 		$6.43M Buy
173,732
+50,988
+42% +$1.99M 0.04% 303
2021
Q4 		$5.58M Buy
122,744
+77,882
+174% +$4.07M 0.03% 345
2021
Q3 		$2.84M Buy
44,862
+16,275
+57% +$1.24M 0.02% 512
2021
Q2 		$2.62M Sell
28,587
-20,756
-42% -$1.65M 0.02% 571
2021
Q1 		$3.36M Buy
49,343
+35,821
+265% +$2.78M 0.02% 416
2020
Q4 		$980K Sell
13,522
-35,856
-73% -$2.08M 0.01% 499
2020
Q3 		$1.87M Buy
49,378
+26,715
+118% +$902K 0.02% 437
2020
Q2 		$803K Buy
22,663
+12,075
+114% +$344K 0.01% 602
2020
Q1 		$231K Sell
10,588
-79,341
-88% -$1.78M 0.01% 491
2019
Q4 		$1.94M Sell
89,929
-110,648
-55% -$2.54M 0.03% 401
2019
Q3 		$4.54M Buy
200,577
+80,986
+68% +$2.24M 0.07% 163
2019
Q2 		$4.3M Buy
119,591
+37,543
+46% +$1.2M 0.08% 197
2019
Q1 		$2.59M Buy
+82,048
New +$2.39M 0.04% 273

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rafferty Asset Management's CDNA Position: Q2 2026 in Review

Rafferty Asset Management reduced its CareDx (CDNA) stake by 60% in Q2 2026, selling an estimated $1.02M and leaving 31,781 shares worth $906K. The position accounts for ﹤0.01% of the portfolio, ranked #803.

Rafferty Asset Management first reported a position in CDNA in Q1 2019 and has held it in 30 quarters since. The position peaked at $6.43M in Q1 2022. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Rafferty Asset Management held 31,781 shares of CareDx worth $906K as of Q2 2026.
  • Rafferty Asset Management sold 46,953 CareDx shares in Q2 2026, an estimated $1.02M.
  • CareDx made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #803 holding.
  • Rafferty Asset Management first reported a position in CareDx in Q1 2019 and has held it in 30 quarters since.
  • Rafferty Asset Management's CareDx position peaked at $6.43M in Q1 2022.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.